[
    [
        {
            "time": "2018-06-29",
            "original_text": "胰岛素龙头甘李药业IPO发行获投资者热捧 网上线下认购率达99.58%",
            "features": {
                "keywords": [
                    "甘李药业",
                    "IPO",
                    "认购率",
                    "胰岛素",
                    "龙头"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "胰岛素龙头甘李药业IPO发行获投资者热捧 网上线下认购率达99.58%",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-06-29",
            "original_text": "发行价格63.32元/股！甘李药业：6月29日在上证所上市",
            "features": {
                "keywords": [
                    "甘李药业",
                    "发行价格",
                    "上证所",
                    "上市"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "发行价格63.32元/股！甘李药业：6月29日在上证所上市",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-06-29",
            "original_text": "甘李药业(603087.SH)将于6月29日上市",
            "features": {
                "keywords": [
                    "甘李药业",
                    "上市",
                    "股票代码"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "甘李药业(603087.SH)将于6月29日上市",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-06-29",
            "original_text": "强敌环伺！甘精胰岛素或独木难支 甘李药业IPO之后前路未卜",
            "features": {
                "keywords": [
                    "甘李药业",
                    "IPO",
                    "甘精胰岛素",
                    "竞争压力"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "强敌环伺！甘精胰岛素或独木难支 甘李药业IPO之后前路未卜",
                "Correlation": 10,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-06-29",
            "original_text": "甘李药业：国内胰岛素“佼佼者”终登A股资本市场再添新活力",
            "features": {
                "keywords": [
                    "甘李药业",
                    "胰岛素",
                    "A股",
                    "资本市场"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "甘李药业：国内胰岛素“佼佼者”终登A股资本市场再添新活力",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-06-29",
            "original_text": "甘李下批文、生物谷过会所释放的信号： 成品药IPO审核口径渐变",
            "features": {
                "keywords": [
                    "甘李药业",
                    "成品药",
                    "IPO审核",
                    "政策信号"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "甘李下批文、生物谷过会所释放的信号： 成品药IPO审核口径渐变",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        }
    ]
]